Aino Kalervo
MSc, MS, Chief Operating Officer
Chief Operating Officer, Aino Kalervo, is trained in both molecular biology and business and has over a decade’s experience in the business development of early stage biologics and therapeutic vaccines. Prior to joining Tiltbio, Aino worked at Sanofi’s Paris office and Theravectys, a French therapeutic vaccine company. Aino is responsible for all aspects of business, including fund raising, business development, and bridging the gap from breakthrough science to product success. Since 2022, she has also served as the President of TILT Biotherapeutics’ U.S. affiliate.
